Loading...
Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion
Myelodysplastic syndrome (MDS) with del(5q) is a unique hematopoietic stem cell disease that typically follows an indolent course and demonstrates particular sensitivity to lenalidomide, a second-generation immunomodulatory agent. Early trials demonstrated rapid and durable responses leading to US F...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573434/ https://ncbi.nlm.nih.gov/pubmed/23556117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620711435659 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|